Michael A. Schlesinger
Net Worth

Last updated:

What is Michael A. Schlesinger net worth?

The estimated net worth of Mr. Michael A. Schlesinger is at least $12,756,859 as of 4 Apr 2022. He owns shares worth $1,545,040 as insider, has earned $7,695,299 from insider trading and has received compensation worth at least $3,516,520 in Ortho Clinical Diagnostics Holdings plc.

What is the salary of Michael A. Schlesinger?

Mr. Michael A. Schlesinger salary is $879,130 per year as Executive Vice President, Gen. Counsel & Sec. in Ortho Clinical Diagnostics Holdings plc.

How old is Michael A. Schlesinger?

Mr. Michael A. Schlesinger is 66 years old, born in 1959.

What stocks does Michael A. Schlesinger currently own?

As insider, Mr. Michael A. Schlesinger owns shares in one company:

Company Title Shares Price per share Total value
Ortho Clinical Diagnostics Holdings plc (OCDX) Executive Vice President, Gen. Counsel & Sec. 87,637 $17.63 $1,545,040

What does Ortho Clinical Diagnostics Holdings plc do?

Ortho Clinical Diagnostics Holdings plc provides in-vitro diagnostics solutions to the clinical laboratory and transfusion medicine communities worldwide. The company offers automated instruments; and assays, reagents, and other consumables that are used by these instruments to generate test results. Its solutions include clinical chemistry and immunoassay instruments and tests to detect and monitor disease progression across a spectrum of therapeutic areas, including COVID-19 antibody and antigen tests; and immunohematology instruments and tests for blood typing to ensure patient-donor compatibility in blood transfusions, as well as donor screening instruments and tests for blood and plasma screening for infectious diseases. The company is also involved in the provision of contract manufacturing and orthocare services. Its products are used in hospitals, laboratories, clinics, blood banks, and donor centers. Ortho Clinical Diagnostics Holdings plc was founded in 1939 and is headquartered in Raritan, New Jersey.

OCDX logo
OCDX
Ortho Clinical Diagnostics Holdings plc
$17.63

Michael A. Schlesinger insider trading

Ortho Clinical Diagnostics Holdings plc

Mr. Michael A. Schlesinger has made 9 insider trades between 2021-2022, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 130,000 units of OCDX stock on 3 Jan 2022. As of 4 Apr 2022 he still owns at least 87,637 units of OCDX stock.

Transaction Date Security Shares Price per share Total value Source
Option
Ordinary Shares, $0.00001 par value 88,043 $6.28 $552,910
Option
Stock Option 88,043 $6.28 $552,910
Sale
Ordinary Shares, $0.00001 par value 88,043 $18.77 $1,652,215
Sale
Ordinary Shares, $0.00001 par value 130,000 $21.09 $2,741,570
Option
Stock Option 130,000 $6.28 $816,400
Option
Ordinary Shares, $0.00001 par value 130,000 $6.28 $816,400
Sale
Ordinary Shares, $0.00001 par value 75,464 $19.73 $1,488,980
Option
Ordinary Shares, $0.00001 par value 75,464 $6.28 $473,914
Option
Stock Option 75,464 $6.28 $473,914
Sale
Ordinary Shares, $0.00001 par value 41,015 $6.28 $257,574
Option
Ordinary Shares, $0.00001 par value 41,015 $20.14 $826,001
Option
Ordinary Shares, $0.00001 par value 41,015 $20.14 $826,001
Option
Stock Option 41,015 $20.14 $826,001
Sale
Ordinary Shares, $0.00001 par value 41,015 $20.14 $826,001
Option
Stock Option 4,000 $6.28 $25,120
Sale
Ordinary Shares, $0.00001 par value 4,000 $6.28 $25,120
Option
Ordinary Shares, $0.00001 par value 4,000 $6.28 $25,120
Sale
Ordinary Shares, $0.00001 par value 4,300 $20 $86,004
Option
Ordinary Shares, $0.00001 par value 4,300 $20 $86,004
Option
Stock Option 4,300 $20 $86,004
Option
Ordinary Shares, $0.00001 par value 8,100 $20 $162,000
Option
Stock Option 8,100 $20 $162,000
Sale
Ordinary Shares, $0.00001 par value 8,100 $20 $162,000
Option
Stock Option 72,585 $6.28 $455,834
Option
Ordinary Shares, $0.00001 par value 72,585 $6.28 $455,834
Sale
Ordinary Shares, $0.00001 par value 72,585 $6.28 $455,834

Ortho Clinical Diagnostics Holdings key executives

Ortho Clinical Diagnostics Holdings plc executives and other stock owners filed with the SEC: